F. Mendes, Eduarda Carias, André Fragoso, A. P. Silva, P. Neves
{"title":"他汀类药物对慢性肾病患者的影响是什么?","authors":"F. Mendes, Eduarda Carias, André Fragoso, A. P. Silva, P. Neves","doi":"10.15406/aowmc.2019.09.00282","DOIUrl":null,"url":null,"abstract":"Dyslipidemia has a high prevalence among patients with chronic kidney disease (CKD) and contribute to the elevated cardiovascular morbidity and mortality, as well as to the progression of the renal disease. Regarding statins renal protective role, owing to their lipid lowering effect, and also to their pleiotropic properties there is some controversy in the literature.1 The use of statins in earlier kidney disease stages could increase renal protection but it might be dosedependent. Some studies suggest that a more prolonged treatment could increase renal protection.1,2","PeriodicalId":93066,"journal":{"name":"Advances in obesity, weight management & control","volume":"84 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"What is statins legacy in chronic kidney disease patients?\",\"authors\":\"F. Mendes, Eduarda Carias, André Fragoso, A. P. Silva, P. Neves\",\"doi\":\"10.15406/aowmc.2019.09.00282\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dyslipidemia has a high prevalence among patients with chronic kidney disease (CKD) and contribute to the elevated cardiovascular morbidity and mortality, as well as to the progression of the renal disease. Regarding statins renal protective role, owing to their lipid lowering effect, and also to their pleiotropic properties there is some controversy in the literature.1 The use of statins in earlier kidney disease stages could increase renal protection but it might be dosedependent. Some studies suggest that a more prolonged treatment could increase renal protection.1,2\",\"PeriodicalId\":93066,\"journal\":{\"name\":\"Advances in obesity, weight management & control\",\"volume\":\"84 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-08-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in obesity, weight management & control\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15406/aowmc.2019.09.00282\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in obesity, weight management & control","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/aowmc.2019.09.00282","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
What is statins legacy in chronic kidney disease patients?
Dyslipidemia has a high prevalence among patients with chronic kidney disease (CKD) and contribute to the elevated cardiovascular morbidity and mortality, as well as to the progression of the renal disease. Regarding statins renal protective role, owing to their lipid lowering effect, and also to their pleiotropic properties there is some controversy in the literature.1 The use of statins in earlier kidney disease stages could increase renal protection but it might be dosedependent. Some studies suggest that a more prolonged treatment could increase renal protection.1,2
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
